Certified by Founder Lodge
Marshall Wace
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $120,000,000
13 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 1997, Marshall Wace is a global asset manager offering a diverse set of alternative, long-only and bespoke investment solutions to a broad range of investors.
Company | Date | Round | Raised |
---|---|---|---|
BlueWhale Bio | September, 08 ,2023 | Unknown | $18,000,000 |
Turtlemint | April, 29 ,2022 | Series E | $120,000,000 |
Parse Biosciences | February, 15 ,2022 | Series B | $41,500,000 |
FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
Prognos Health | May, 18 ,2023 | Unknown | $23,000,000 |
Attovia Therapeutics | May, 14 ,2024 | Series B | $105,000,000 |
ADARx Pharmaceuticals Inc. | August, 10 ,2023 | Series C | $200,000,000 |
Inquis Medical, Inc. | November, 05 ,2024 | Series B | $40,000,000 |
Beta Bionics | September, 04 ,2023 | Series D | $100,000,000 |
BlueWhale Bio | September, 08 ,2023 | Unknown | $18,000,000 |
FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
Attovia Therapeutics | May, 14 ,2024 | Series B | $105,000,000 |
Inquis Medical, Inc. | November, 05 ,2024 | Series B | $40,000,000 |